BioMarin Pharmaceutical
BMRN
#1392
Rank
S$16.95 B
Marketcap
$88.98
Share price
1.02%
Change (1 day)
-29.51%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): S$0.51 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$2.75 Billion. In 2023 the company made an earning of S$0.25 Billion, an increase over its 2022 earnings that were of S$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.51 B103.25%
2023 S$0.25 B26.07%
2022 S$0.20 B-298.51%
2021 -S$0.11 Billion78.04%
2020 -S$57.36 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.2 Billion297.78%
2017 -S$48.62 Million-95.68%
2016 -S$1.13 Billion437.12%
2015 -S$0.21 Billion23.91%
2014 -S$0.17 Billion-29.25%
2013 -S$0.24 Billion49.23%
2012 -S$0.17 Billion171.11%
2011 -S$59.12 Million103.01%
2010 -S$29.13 Million-3903.54%
2009 S$0.76 M-98.31%
2008 S$45.29 M-189.7%
2007 -S$50.5 Million51.02%
2006 -S$33.44 Million-61.58%
2005 -S$87.02 Million-56.59%
2004 -S$0.21 Billion95.13%
2003 -S$0.11 Billion12.09%
2002 -S$91.64 Million73.19%
2001 -S$52.92 Million18.32%
2000 -S$44.72 Million19.65%
1999 -S$37.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.68 Billion-226.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.19 Billion-134.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$39.15 Million-107.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.03 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-S$92.63 Million-117.46%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.25 B-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA